BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26699584)

  • 1. Seed coordinates of a new COMS-like 24 mm plaque verified using the FARO Edge.
    McCauley Cutsinger SE; Furutani KM; Forsman RM; Corner SM
    J Appl Clin Med Phys; 2015 Nov; 16(6):293-301. PubMed ID: 26699584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
    McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
    Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and dosimetric considerations of a modified COMS plaque: the reusable "seed-guide" insert.
    Astrahan MA; Szechter A; Finger PT
    Med Phys; 2005 Aug; 32(8):2706-16. PubMed ID: 16193802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 16 mm OSU-Nag and COMS eye plaques.
    Zhang H; Davidorf F; Qi Y
    J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental measurements and Monte Carlo calculations for (103)Pd dosimetry of the 12 mm COMS eye plaque.
    Saidi P; Sadeghi M; Tenreiro C
    Phys Med; 2013 May; 29(3):286-94. PubMed ID: 22592132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation.
    Zimmermann LW; Amoush A; Wilkinson DA
    J Appl Clin Med Phys; 2015 Nov; 16(6):226-239. PubMed ID: 26699577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 125I eye plaque dose distribution including penumbra characteristics.
    de la Zerda A; Chiu-Tsao ST; Lin J; Boulay LL; Kanna I; Kim JH; Tsao HS
    Med Phys; 1996 Mar; 23(3):407-18. PubMed ID: 8815384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
    Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
    Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous dose calculations for Collaborative Ocular Melanoma Study eye plaques using actual seed configurations and Task Group Report 43 formalism.
    Deufel CL; Furutani KM
    Brachytherapy; 2015; 14(2):209-30. PubMed ID: 25533415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging errors in localization of COMS-type plaques in choroidal melanoma brachytherapy.
    Bayat M; Alizad A; Tamminga R; Pulido JS; Fatemi M
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6852-60. PubMed ID: 24052637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
    Johnson JE; Deufel CL; Furutani KM
    Brachytherapy; 2016; 15(5):661-8. PubMed ID: 27475484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving quality assurance for assembled COMS eye plaques using a pinhole gamma camera.
    Beiki-Ardakani A; Jezioranski J; Jaffray DA; Young I
    Med Phys; 2008 Oct; 35(10):4318-23. PubMed ID: 18975677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric benefit of a new ophthalmic radiation plaque.
    Marwaha G; Wilkinson A; Bena J; Macklis R; Singh AD
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1226-30. PubMed ID: 22658440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.